Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

Abstract

Introduction Reduced estimated creatinine clearance (eCrCl) is prevalent in older patients and impacts on drug prescription. In this study, the burden of eCrCl reduction and its associated factors and impact on outcomes were analyzed. Moreover, the rate of inappropriate drug prescription according to eCrCl and its impact on outcomes were described. Methods Data were obtained from "REgistro POliterapie SIMI" (REPOSI), a prospective observational register enrolling hospitalized patients aged ≥ 65 years. Patients enrolled from 2010-2016 with available data to calculate eCrCl according to the Cockcroft-Gault formula were included in this analysis. Results A total of 5046 patients were available for analysis. Among these, we found an eCrCl of 45-59 mL/min in 1163 patients (23.0%), an eCrCl of 30-44 mL/min in 1128 (22.4%), an eCrCl of 15-29 mL/min in 702 (13.9%), and an eCrCl < 15 mL/min in 152 (3.0%), with several clinical factors associated with decreasing eCrCl. During follow-up, a progressively higher risk for all-cause death, cardiovascular (CV) death, any death/re-hospitalization, and CV death/re-hospitalization was found across the renal function classes. Among patients with hypertension, diabetes mellitus, atrial fibrillation, coronary artery disease, and heart failure, 476 (10.9%) were inappropriately prescribed medications according to eCrCl. During followup, inappropriate prescription was associated with increased risk of all-cause death (odds ratio [OR] 1.49, 95% confidence interval [CI] 1.13-1.97) and any death/re-hospitalization (OR 1.30, 95% CI 1.03-1.63). Conclusions In older hospitalized patients, impaired eCrCl is prevalent and associated with several factors, polypharmacy in particular. Patients with reduced eCrCl have a higher risk of major clinical outcomes, and > 10% of them are prescribed an inappropriate drug, with a higher risk for major clinical outcomes.Antonietta Gigante and Marco Proietti contributed equally to the manuscript.

Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease

“…In general, older subjects tend to be at a higher risk of metabolic disorders and atherosclerotic diseases [20,21], and their renal function is vulnerable to several treatment interventions [22]. Therefore, such a risk of impaired renal function represents a barrier to the use of the most appropriate drug intervention.…”

Renally Inappropriate Medications in the Old Population: Prevalence, Risk Factors, Adverse Outcomes, and Potential Interventions

“…According to a retrospective study conducted at a university hospital in Stockholm, Sweden, adverse drug reactions accounted for 14% of admissions, while impaired renal function accounted for one-third [ 56 ]. An Italian study of older patients with renal impairment found that RIM use was independently associated with a 46% increase in mortality [ 27 ] and a 40% increase in mortality in a French population-based study [ 36 ]. RIMs, however, were not associated with hospitalization or death in one study of community-dwelling older adults [ 24 ].…”

Prescribing Renally Inappropriate Medication to Hospitalized Geriatric Patients in Makkah, Saudi Arabia

“… 14 According to studies of older patients with renal impairment, use of RIM was associated with an increase in mortality of 40% to 46%. 11 , 15 Moreover, exposure to nephrotoxic medications increased healthcare utilization, including prescription drug use, emergency department visits, and hospitalizations. A study has demonstrated that total health expenditures were nearly 30% higher in groups exposed to nephrotoxic medications than in those who were not exposed.…”